Jiangsu Hengrui Medicine
600276.SS
#525
Rank
โ‚น4.504 T
Marketcap
โ‚น678.69
Share price
0.29%
Change (1 day)
-13.48%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): โ‚น7.46

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is โ‚น13.89. In 2022 the company made an earnings per share (EPS) of โ‚น8.54 a decrease over its 2021 EPS that were of โ‚น10.30.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น7.46-12.7%
2022โ‚น8.54-17.1%
2021โ‚น10.30-24.44%
2020โ‚น13.6420.3%
2019โ‚น11.3425.58%
2018โ‚น9.0327.55%
2017โ‚น7.0821.64%
2016โ‚น5.8213.57%
2015โ‚น5.1239.86%
2014โ‚น3.6621.33%
2013โ‚น3.0217.7%
2012โ‚น2.5625.56%
2011โ‚น2.0426.22%
2010โ‚น1.6210.3%
2009โ‚น1.4757.92%
2008โ‚น0.9311.06%
2007โ‚น0.8485.81%
2006โ‚น0.4587.94%
2005โ‚น0.2433.97%
2004โ‚น0.1829.78%
2003โ‚น0.1419.78%
2002โ‚น0.12